Cited by 256Mitochondrial Function and PathologyCoenzyme Q10 studies and effectsAdipose Tissue and Metabolism

Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1

Open access
Bouitbir, Jamal, Charles, Anne-Laure, Echaniz-Laguna, Andoni, Kindo, Michel, Daussin, Frédéric, Auwerx, Johan, Piquard, François, Geny, Bernard +1 more·2012·European Heart Journal

Abstract

AIMS: Statins protect against cardiovascular-related mortality but induce skeletal muscle toxicity. To investigate mechanisms of statins, we tested the hypothesis that statins optimized cardiac mitochondrial function but impaired vulnerable skeletal muscle by inducing different level of reactive oxygen species (ROS). METHODS AND RESULTS: In atrium of patients treated with statins, ROS production was decreased and oxidative capacities were enhanced together with an extensive augmentation of mRNAs expression of peroxisome proliferator-activated receptor gamma co-activator (PGC-1) family. However, in deltoid biopsies from patients with statin-induced muscular myopathy, oxidative capacities were decreased together with ROS increase and a collapse of PGC-1 mRNA expression. Several animal and cell culture experiments were conducted and showed by using ROS scavengers that ROS production was the triggering factor responsible of atorvastatin-induced activation of mitochondrial biogenesis pathway and improvement of antioxidant capacities in heart. Conversely, in skeletal muscle, the large augmentation of ROS production following treatment induced mitochondrial impairments, and reduced mitochondrial biogenesis mechanisms. Quercetin, an antioxidant molecule, was able to counteract skeletal muscle deleterious effects of atorvastatin in rat. CONCLUSION: Our findings identify statins as a new activating factor of cardiac mitochondrial biogenesis and antioxidant capacities, and suggest the importance of ROS/PGC-1 signalling pathway as a key element in regulation of mitochondrial function in cardiac as well as skeletal muscles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr224

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other studies have shown increased ROS production and decreased antioxidant capacity with statin treatment.

    “other studies have shown increased ROS production (3,42) and a decreased antioxidant capacity (3) with statin treatment.”

    From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [3]

  • Reduced antioxidant capacity combined with known elevated ROS production makes it plausible that increased apoptosis contributes to muscle pain in statin-treated patients.

    “Our findings of significantly reduced antioxidant capacity in combination with the known (3,40) elevated ROS production in the simvastatin-treated patients make it plausible that increased apoptosis could contribute to muscle pain in patients treated with statins.”

    From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [3]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bouitbir, J., Charles, A.-L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., & Zoll, J.
Affiliations
  • Hôpital Civil, Strasbourg (FR)
  • École Polytechnique Fédérale de Lausanne (CH)
Corresponding author
Zoll, Joffrey
Venue
European Heart Journal
Published
2011-07-20
Volume
33
Issue
11
Pages
1397-1407
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2102743559
Cited by
256
References
30
Citations by year
2026: 8 · 2025: 17 · 2024: 13 · 2023: 14 · 2022: 18 · 2021: 12 · 2020: 24 · 2019: 22 · 2018: 18 · 2017: 22 · 2016: 25 · 2015: 18 · 2014: 9 · 2013: 17 · 2012: 16
FWCI
5.72
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • reroDoc Digital Library (submittedVersion)
  • HAL (submittedVersion)
  • edoc (University of Basel) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • National Science Foundation
  • Institut National de la Santé et de la Recherche Médicale
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-59820, P01DK059820)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
statins, atorvastatin, statin-induced myopathy, heart mitochondria, skeletal muscle mitochondria, reactive oxygen species, PGC-1, mitochondrial biogenesis, oxidative stress, antioxidant capacity, quercetin, mitohormesis, cardioprotection
MeSH terms
Atorvastatin, Animals, Antioxidants, Heart Atria, Heptanoic Acids, Humans, Male, Mitochondria, Heart, Mitochondria, Muscle, Pyrroles, Quercetin, RNA, Messenger, Superoxide Dismutase, Transcription Factors, Rats, Wistar, Reactive Oxygen Species, Muscle, Skeletal, Muscle Fibers, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocytes, Cardiac, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review